Quest Diagnostics Incorporated
DGX
$175.40
$1.640.94%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 897.00M | 871.00M | 841.00M | 840.00M | 846.00M |
| Total Depreciation and Amortization | 517.00M | 493.00M | 467.00M | 453.00M | 448.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 185.00M | 171.00M | 149.00M | 121.00M | 117.00M |
| Change in Net Operating Assets | -105.00M | -201.00M | -60.00M | -166.00M | -79.00M |
| Cash from Operations | 1.49B | 1.33B | 1.40B | 1.25B | 1.33B |
| Capital Expenditure | -438.00M | -425.00M | -374.00M | -373.00M | -385.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -2.02B | -2.16B | -1.78B | -250.00M | -722.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.00M | 41.00M | -5.00M | -11.00M | -9.00M |
| Cash from Investing | -2.45B | -2.55B | -2.16B | -634.00M | -1.12B |
| Total Debt Issued | 2.06B | 1.85B | 2.74B | 1.45B | 2.45B |
| Total Debt Repaid | -903.00M | -303.00M | -720.00M | -1.32B | -1.70B |
| Issuance of Common Stock | 90.00M | 73.00M | 64.00M | 53.00M | 59.00M |
| Repurchase of Common Stock | -194.00M | -175.00M | -299.00M | -298.00M | -298.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -336.00M | -331.00M | -327.00M | -323.00M | -319.00M |
| Other Financing Activities | -42.00M | -26.00M | -69.00M | -29.00M | -107.00M |
| Cash from Financing | 676.00M | 1.08B | 1.38B | -469.00M | 83.00M |
| Foreign Exchange rate Adjustments | -6.00M | -7.00M | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -286.00M | -137.00M | 621.00M | 145.00M | 299.00M |